Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Bamifylline
2. Bamiphylline
3. Benzetamophylline
4. Trentadil
1. 20684-06-4
2. Bamifylline Hcl
3. Bamiphylline Hydrochloride
4. 8102 Cb
5. Ac 3810
6. Bamifylline Hydrochloride [usan]
7. Bax 2739z
8. 20684-06-4 (hcl)
9. 3736-86-5
10. Bax-2739z
11. 66466qlm3s
12. 8-benzyl-7-(2-(ethyl(2-hydroxyethyl)amino)ethyl)theophylline Monohydrochloride
13. 8-benzyl-7-[2-[ethyl(2-hydroxyethyl)amino]ethyl]-1,3-dimethylpurine-2,6-dione;hydrochloride
14. 1h-purine-2,6-dione, 7-(2-(ethyl(2-hydroxyethyl)amino)ethyl)-3,7-dihydro-1,3-dimethyl-8-(phenylmethyl)-, Monohydrochloride
15. 8102-cb
16. Ac-3810
17. Trentadil
18. Pulmac
19. Dsstox_cid_28647
20. Dsstox_rid_82917
21. Dsstox_gsid_48721
22. Bamifylline Hydrochloride (usan)
23. Briofil
24. Mono-hcl
25. 8-benzyl-7-(2-(ethyl(2-hydroxyethyl)amino)ethyl)-1,3-dimethyl-3,7-dihydro-1h-purine-2,6-dione Hydrochloride
26. Benzetamophylline Hydrochloride
27. Cas-20684-06-4
28. Bax 2793z
29. Ncgc00182061-02
30. Einecs 243-967-6
31. Cb 8102
32. Unii-66466qlm3s
33. 8'-benzyl-7-(2-(ethyl(2-hydroxyethyl)amino)ethyl)theophylline Hydrochloride
34. 8-benzyl-7-(n-ethyl-n-(beta-hydroxyethyl)aminoethyl)theophylline Hydrochloride
35. 7-(n-(beta-hydroxyethyl)-n-ethyl)-aminoethyl-8-benzyl-theophylline Hydrochloride
36. Schembl637064
37. Chembl2105899
38. Dtxsid4048721
39. Glxc-26021
40. Tox21_113133
41. Bamifylline Hydrochloride [mi]
42. Akos025392166
43. Tox21_113133_1
44. Ks-1411
45. 8-benzyl-7-[2-[ethyl(2-hydroxyethyl)amino]ethyl]-1,3-dimethylpurine-2,6-dione Hydrochloride
46. Theophylline, 8-benzyl-7-(2-(ethyl(2-hydroxyethyl)amino)ethyl)-, Monohydrochloride
47. Bamifylline Hydrochloride [mart.]
48. Ncgc00182061-03
49. 1h-purine-2,6-dione, 7-(2-(ethyl(2-hydroxyethyl)amino)ethyl)-3,7-dihydro-1,3-dimethyl-8-(phenylmethyl)-, Hydrochloride (1:?)
50. Bamifylline Hydrochloride [who-dd]
51. D03051
52. Q27263955
53. 1h-purine-2,6-dione, 7-(2-(ethyl(2-hydroxyethyl)amino)ethyl)-3,7-dihydro-1,3-dimethyl-8-(phenylmethyl)-, Hydrochloride (1:1)
Molecular Weight | 421.9 g/mol |
---|---|
Molecular Formula | C20H28ClN5O3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 8 |
Exact Mass | 421.1880675 g/mol |
Monoisotopic Mass | 421.1880675 g/mol |
Topological Polar Surface Area | 81.9 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 554 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
ABOUT THIS PAGE
A Bamifylline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bamifylline, including repackagers and relabelers. The FDA regulates Bamifylline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bamifylline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bamifylline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bamifylline supplier is an individual or a company that provides Bamifylline active pharmaceutical ingredient (API) or Bamifylline finished formulations upon request. The Bamifylline suppliers may include Bamifylline API manufacturers, exporters, distributors and traders.
click here to find a list of Bamifylline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bamifylline DMF (Drug Master File) is a document detailing the whole manufacturing process of Bamifylline active pharmaceutical ingredient (API) in detail. Different forms of Bamifylline DMFs exist exist since differing nations have different regulations, such as Bamifylline USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bamifylline DMF submitted to regulatory agencies in the US is known as a USDMF. Bamifylline USDMF includes data on Bamifylline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bamifylline USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bamifylline suppliers with USDMF on PharmaCompass.
A Bamifylline written confirmation (Bamifylline WC) is an official document issued by a regulatory agency to a Bamifylline manufacturer, verifying that the manufacturing facility of a Bamifylline active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bamifylline APIs or Bamifylline finished pharmaceutical products to another nation, regulatory agencies frequently require a Bamifylline WC (written confirmation) as part of the regulatory process.
click here to find a list of Bamifylline suppliers with Written Confirmation (WC) on PharmaCompass.
Bamifylline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bamifylline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bamifylline GMP manufacturer or Bamifylline GMP API supplier for your needs.
A Bamifylline CoA (Certificate of Analysis) is a formal document that attests to Bamifylline's compliance with Bamifylline specifications and serves as a tool for batch-level quality control.
Bamifylline CoA mostly includes findings from lab analyses of a specific batch. For each Bamifylline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bamifylline may be tested according to a variety of international standards, such as European Pharmacopoeia (Bamifylline EP), Bamifylline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bamifylline USP).
LOOKING FOR A SUPPLIER?